Egg Freezing and Embryo Banking Market Report 2026

The egg freezing and embryo banking market size has grown rapidly in recent years. It will grow from $4.45 billion in 2025 to $5.07 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to career prioritization trends, oncology-related fertility preservation, ivf clinic expansion, reproductive health awareness, urban lifestyle changes.

The egg freezing and embryo banking market size is expected to see rapid growth in the next few years. It will grow to $8.07 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to social egg freezing acceptance, advanced cryogenic storage, employer fertility benefits, fertility tourism growth, regulatory support for art. Major trends in the forecast period include rising demand for fertility preservation services, increasing adoption of delayed parenthood planning, growing use of cryopreservation technologies, expansion of fertility awareness programs, improved success rates of assisted reproductive techniques.

The rise of social freezing is expected to drive the growth of the egg-freezing and embryo banking markets in the coming years. Social freezing involves a woman undergoing ovarian stimulation, egg retrieval, and freezing of her eggs for non-medical reasons. This trend is fueled by individuals seeking to preserve fertility and retain the option of having children later in life due to career goals, educational pursuits, lack of a partner, or financial considerations. Egg freezing and embryo banking support reproductive planning by providing long-term fertility preservation options, allowing informed decisions about future family building. For instance, in June 2025, according to the Human Fertilisation and Embryology Authority (HFEA), a UK-based regulatory body, egg-freezing cycles increased from 4,700 in 2022 to 6,900 in 2023, representing 7% of all treatment and storage cycles. Therefore, the rise in social freezing is fueling the growth of the egg-freezing and embryo banking market.

Companies in the egg-freezing and embryo banking markets are focusing on developing innovative fertility preservation banks to provide comprehensive preservation solutions. Preservation banks offer frozen donor eggs to intended parents, serving as an alternative to fresh eggs. For example, in March 2023, Pinnacle Fertility, a US-based fertility services provider, launched Pinnacle Egg Bank to expand nationwide access to egg donor options. This solution offers access to high-quality frozen donor eggs, a thorough donor screening process, expertise in egg donation and cryopreservation, a streamlined and integrated patient journey, and success rates comparable to those of fresh eggs.

In June 2023, Pinnacle Fertility, a US-based fertility services provider, partnered with TMRW Life Sciences to implement advanced technology for the safe management and storage of frozen eggs and embryos. Through this partnership, Pinnacle aims to elevate the standard of care across its network clinics by modernizing specimen management and improving safety, accuracy, efficiency, and transparency. TMRW Life Sciences is a US-based company providing an automated platform for egg freezing and embryo banking.

Major companies operating in the egg freezing and embryo banking market are Mayo Clinic, Cleveland Clinic Fertility Center, The Cooper Companies Inc., Reproductive Medicine Associates Network LLC, Shady Grove Fertility, Virtus Health Limited, Monash IVF Group Limited, Kindbody Inc., Carrot Fertility Inc., CREATE Fertility Limited, New England Cryogenic Center Inc., CCRM Management Company LLC, Reproductive Biology Associates LLC, Genea Limited, WINFertility Inc., California Cryobank Inc., Fairfax Cryobank Inc., Institut Marquès, Extend Fertility Medical Practice PLLC, The London Women’s Clinic Limited, Kitazato Corporation, ReproTech LLC, IVF Australia, CHA Medical Group Inc., West Coast Fertility Centers Inc.

Europe was the largest region in the egg freezing and embryo banking market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the egg freezing and embryo banking market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the egg freezing and embryo banking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the egg freezing and embryo banking market by increasing costs of imported cryopreservation equipment, laboratory consumables, and storage systems. Fertility centers and cryo banks in developed regions are most affected due to reliance on imported technologies. These tariffs raise service costs by increasing capital investment and operational expenses for cryogenic storage and laboratory processing, affecting affordability of fertility preservation services. However, they encourage domestic manufacturing of fertility lab equipment, supporting localized production of cryopreservation systems and consumables.

The egg freezing and embryo banking market research report is one of a series of new reports that provides egg freezing and embryo banking market statistics, including egg freezing and embryo banking industry global market size, regional shares, competitors with a egg freezing and embryo banking market share, detailed egg freezing and embryo banking market segments, market trends and opportunities, and any further data you may need to thrive in the egg freezing and embryo banking industry. This egg freezing and embryo banking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Egg freezing and embryo banking are assisted reproductive technologies that enable individuals to preserve their fertility for future use. These procedures allow people to store eggs or embryos at their current age and pursue parenthood when they are ready.

The main types of egg freezing and embryo banking are donor and non-donor. Donor eggs or embryos are provided by another individual or couple for use in fertility treatments. Both egg freezing and embryo freezing can be used for preservation. These services are applicable for females under 30 years and over 30 years and are offered by end users such as fertility centers, hospitals, cryobanks, and others.

The egg freezing and embryo banking market includes revenues earned by entities through services such as ovarian stimulation, egg retrieval, in vitro fertilization, embryo selection, and embryo thawing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.